Login / Signup

Efficacy and Safety of Once-Weekly Thyroxine for Thyroxine-Resistant Hypothyroidism.

Chellama JayakumariAbilash NairJabbar Puthiyaveettil KhadarDarvin V DasNandini PrasadS J JessyAnjana GopiPadmanabhan Guruprasad
Published in: Journal of the Endocrine Society (2019)
OWT benefits a majority of patients in the long-term treatment of thyroxine-resistant hypothyroidism, in the real-world setting.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • replacement therapy
  • chronic kidney disease
  • ejection fraction
  • peritoneal dialysis
  • prognostic factors